检索结果 - Mary Flanagan Quinn

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors 由 Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker, Sonya Zabludoff, Felix Agbo, Patricia Oakes, Adrian M. Senderowicz

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors

    Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors 由 Patricia LoRusso, Martin J. Edelman, S. Bever, Karen Forman, MaryJo Pilat, Mary Flanagan Quinn, Jing Li, Elisabeth I. Heath, Lisa Malburg, Patrick Klein, Christopher P. Leamon, Richard A. Messmann, Edward A. Sausville

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: